Your browser doesn't support javascript.
loading
Locoregional Treatment in Intrahepatic Cholangiocarcinoma: Which Treatment for Which Patient?
Bourien, Héloïse; Pircher, Chiara Carlotta; Guiu, Boris; Lamarca, Angela; Valle, Juan W; Niger, Monica; Edeline, Julien.
Afiliación
  • Bourien H; Medical Oncology Department, Centre Eugène Marquis, 35000 Rennes, France.
  • Pircher CC; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milano, Italy.
  • Guiu B; Interventional Radiology Department, CHU de Montpellier, 34090 Montpellier, France.
  • Lamarca A; Oncology Department, Fundación Jiménez Díaz University Hospital, 28022 Madrid, Spain.
  • Valle JW; Medical Oncology Department, Division of Cancer Sciences, University of Manchester, Manchester M13 9PL, UK.
  • Niger M; The Christie NHS Foundation Trust, Manchester M20 4BX, UK.
  • Edeline J; Medical Oncology Department, Division of Cancer Sciences, University of Manchester, Manchester M13 9PL, UK.
Cancers (Basel) ; 15(17)2023 Aug 23.
Article en En | MEDLINE | ID: mdl-37686493
ABSTRACT
For unresectable intrahepatic cholangiocarcinoma (iCC), different locoregional treatments (LRT) could be proposed to patients, including radiofrequency ablation (RFA) and microwave ablation (MWA), external beam radiotherapy (EBRT) or transarterial treatments, depending on patient and tumor characteristics and local expertise. These different techniques of LRT have not been compared in a randomized clinical trial; most of the relevant studies are retrospective and not comparative. The aim of this narrative review is to help clinicians in their everyday practice discuss the pros and cons of each LRT, depending on the individual characteristics of their patients.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Francia